<aside> ⚠️ Note: Please do not share this page outside the Seaside Ventures ecosystem.
</aside>
Seaside Ventures is pioneering the future of consumer health technology. Positioned within the vast $4 trillion healthcare market, we're investing in emerging technologies to address longstanding health challenges and transform everyday lives.
Our mission? To elevate the mental and physical well-being of over a billion people globally, ensuring our portfolio's products and services become integral to enhancing their quality of life.
Below are Seaside's Requests for Startups (RFS). These outline the general problems we're aiming to help solve.
See yourself fitting in? Get in touch here.
Exploring innovative solutions for the complex spectrum of women’s health issues—from menstrual disorders to postpartum depression—is crucial. These conditions, often underdiagnosed and stigmatized, severely impact daily life and require advanced treatments and awareness strategies that go beyond current standards.
<aside> 💡
Menstrual disorders like PMDD and PMS significantly impair the lives of women and AFAB individuals, affecting an estimated 31 million globally with PMDD alone. These conditions cause severe mood swings, physical discomfort, and cognitive issues and are often underdiagnosed. Nearly 48% experience PMS, indicating a widespread issue. Current treatments, including Ibuprofen and SSRIs, are outdated, underscoring an urgent need for innovative solutions. The prevalence and severe impact of these disorders, particularly PMDD's association with increased suicidal ideation, highlight the critical need for enhanced diagnostics, awareness, and treatment options.
</aside>
<aside> 💡 Menopause, experienced by up to 80% of women, brings symptoms like hot flashes, sleep issues, and mood changes, significantly affecting life quality. Despite hormone therapy (HT) being a primary treatment, its risks prompt many to seek alternatives. Awareness and understanding of menopausal hormone therapy (MHT) are low, with a notable gap in digital education. Many view menopause as a natural life stage, hesitating to pursue MHT due to concerns over its 'naturalness.' Yet, nearly half feel ill-equipped to manage symptoms, highlighting a need for better information and support, underscoring the importance of healthcare professional guidance in managing menopause effectively.
</aside>
<aside> 💡 Endometriosis affects around 190 million women globally, causing severe pain, infertility, and psychological issues, with no cure and treatments focusing on symptom management. Diagnosis is often delayed by 7-10 years due to symptom diversity, normalization of menstrual pain, lack of awareness, and invasive diagnostic procedures. This delay exacerbates the condition's impact, indicating a critical need for innovation in early detection and pain management. Startups have the opportunity to bridge these gaps, offering new solutions for early detection and effective symptom management in this under-addressed area.
</aside>
<aside> 💡 Postpartum depression (PPD) affects 15-20% of new mothers worldwide, yet only 15% receive adequate care, highlighting significant treatment gaps. PPD's complex nature, encompassing symptoms like anxiety and psychosis, complicates its management. The condition is influenced by diverse risk factors, emphasizing the need for early detection and comprehensive treatment. Current pharmacological treatments, mainly antidepressants, have limitations, particularly for breastfeeding mothers. This situation underscores an urgent need for innovative, safe, and effective solutions tailored to maternal mental health challenges. Startups play a crucial role in developing accessible tools and therapies, offering new hope for mothers facing PPD.
</aside>